Regenerative medicine corporations T&R Biofab said on the 2nd that it has completed registration of a U.S. patent related to a “bio-ink supply system technology,” which is essential for mass-producing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback